Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTOR® Peptide Enhanced Bone Graft (P-15/ABM) is only the second FDA PMA Approved bone graft on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year and maintained at two years. i-FACTOR® is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.
Brands: i-FACTOR® Putty is available in the USA and many countries around the world. i-FACTOR® Flex FR is sold outside of the USA.